https://www.selleckchem.com/pr....oducts/ozanimod-rpc1
The purpose of this study is to determine the effect of Apis dorsata Honey as a complementary therapy on IL-37 levels and fatigue in breast cancer patients undergoing chemotherapy. The study used a quasi-experimental pretest-posttest design with a control group. A total of 30 subjects were recruited using a concurrent sampling technique. The intervention group consisted of 15 subjects who received oral honey at a dose of 13ml (1 tablespoon × 3) for 15 days, and the control group consisted of 15 subjects. The groups' samples wer
Curtir
Comentario
Compartilhar
